SLC1A2 and Alzheimer disease: Glutamate transporter-1 (GLT-1) is the dominant glutamate transporter expressed by astrocytes in the brain and has been found to be significantly reduced or damaged in neurodegenerative diseases related with diabetes such as AD and cognitive impairment [57].